CD11c+ myeloid cell exosomes reduce intestinal inflammation during colitis

Area of Science:

• Immunology
• Gastroenterology
• Cell Biology

Background:

• Intercellular communication via exosomes is vital for mammalian homeostasis, particularly in the gastrointestinal (GI) tract.
• The function of immune cell exosomes in regulating GI homeostasis and inflammation remains largely unknown.
• Exosomes are nanoscale lipid vesicles facilitating cell-to-cell communication.

Purpose of the Study:

• To investigate the role of immune cell exosomes in regulating GI homeostasis and inflammation.
• To explore the therapeutic potential of dendritic cell (DC)-derived exosomes in colitis.
• To identify specific microRNAs (miRNAs) involved in exosome-mediated immune regulation within the gut.

Main Methods:

• Generated mouse strains with cell-specific exosome production deficiencies (Rab27A deletion in CD11c+ cells).
• Induced and treated murine colitis models, assessing therapeutic effects of DC-derived exosomes.
• Profiled RNAs, particularly miRNAs, within colon and DC-derived exosomes.
• Investigated miRNA transfer mechanisms and target genes in macrophages.
• Analyzed clinical samples from ulcerative colitis patients.

Main Results:

• Deletion of Rab27A in CD11c+ cells exacerbated murine colitis.
• Administration of DC-derived exosomes reversed colitis symptoms.
• A distinct subset of miRNAs was identified in colon and DC exosomes, with miR-146a showing anti-inflammatory properties.
• miR-146a was transferred from gut immune cells to myeloid and T cells via a Rab27-dependent pathway, targeting key inflammatory genes in macrophages.
• A novel exosome-mediated crosstalk between DCs and macrophages was identified, promoting an anti-inflammatory gut macrophage phenotype.
• RAB27A, specific miRNAs, and RNA-binding proteins were dysregulated in ulcerative colitis patient samples.

Conclusions:

• Exosomes play a crucial role in regulating gut inflammation through mechanisms like miRNA transfer.
• DC-derived exosomes hold therapeutic potential for inflammatory bowel disease (IBD).
• The study identifies a novel exosome-mediated regulatory pathway in the gut and provides a basis for exosome-based IBD therapies.